Inventor · disambiguated record
Cornelia Forster
Also filed as: FORSTER CORNELIA · FORSTER CORNELIA J · FORSTER CORNELIA JUTTA
36 granted patents·6 pending applications·1,277 citations·filing 1990–2022
98Inventor score
Top patents by PatentIndex Score
42 records- 0199US6613776B2Pyrazole compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2001·Granted Sep 2, 2003·178 cites·28 claims
- 0298US7691853B2Pyrazole compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2006·Granted Apr 6, 2010·73 cites·9 claims
- 0398US7008948B2Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2003·Granted Mar 7, 2006·142 cites·16 claims
- 0498US6696452B2Pyrazole compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2001·Granted Feb 24, 2004·170 cites·21 claims
- 0598US6660731B2Pyrazole compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2001·Granted Dec 9, 2003·159 cites·15 claims
- 0697US7390815B2Pyrazole compounds useful as protein kinase inhibitorsVERTEX PHARMA·Filed 2003·Granted Jun 24, 2008·114 cites·17 claims
- 0794US10751417B2Sustained release delivery systems comprising traceless linkersNOVARTIS AG·Filed 2018·Granted Aug 25, 2020·11 cites·9 claims
- 0894US8524720B2Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitorsBEBBINGTON DAVID·Filed 2010·Granted Sep 3, 2013·25 cites·9 claims
- 0994US6531474B1Inhibitors of caspasesVERTEX PHARMA·Filed 2000·Granted Mar 11, 2003·62 cites·15 claims
- 1093US7872129B2Compositions useful as inhibitors of GSK-3VERTEX PHARMA·Filed 2008·Granted Jan 18, 2011·43 cites·14 claims
- 1193US7598245B2Aminotriazole compounds useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2007·Granted Oct 6, 2009·25 cites·22 claims
- 1290US5449687A4-phenyl-1,2-cyclohexyl derivatives and anti-inflammatory compositions and methods thereofSMITHKLINE BEECHAM CORP·Filed 1994·Granted Sep 12, 1995·31 cites·6 claims
- 1389US7109357B2Process and intermediates for making substituted aspartic acid acetalsVERTEX PHARMA·Filed 2002·Granted Sep 19, 2006·20 cites·39 claims
- 1488US7279469B2Diaminotriazoles useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2003·Granted Oct 9, 2007·36 cites·15 claims
- 1587US7491730B2Compositions useful as inhibitors of GSK-3VERTEX PHARMA·Filed 2003·Granted Feb 17, 2009·35 cites·15 claims
- 1684US8741912B2Deazapurines useful as inhibitors of Janus kinasesLEDEBOER MARK·Filed 2007·Granted Jun 3, 2014·5 cites·6 claims
- 1782US8703761B2Organic compoundsFORSTER CORNELIA JUTTA·Filed 2009·Granted Apr 22, 2014·11 cites·14 claims
- 1882US5449686ACompounds useful for treating allergic or inflammatory diseasesSMITHKLINE BEECHAM CORP·Filed 1994·Granted Sep 12, 1995·36 cites·6 claims
- 1979US5605923ACompounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factorSMITHKLINE BEECHAM CORP·Filed 1993·Granted Feb 25, 1997·40 cites·6 claims
- 2077US12433949B2Sustained release delivery systems comprising traceless linkersNOVARTIS AG·Filed 2022·Granted Oct 7, 2025·0 cites·7 claims
- 2177US7226920B2Aminotriazole compounds useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2004·Granted Jun 5, 2007·9 cites·8 claims
- 2276US8691848B2Inhibitors of caspasesWANNAMAKER MARION W·Filed 2008·Granted Apr 8, 2014·2 cites·17 claims
- 2373US7358273B2Inhibitors of caspasesVERTEX PHARMA·Filed 2002·Granted Apr 15, 2008·5 cites·15 claims
- 2466US5631286ACompounds useful for treating allergic or inflammatory diseasesSMITHKLINE BEECHAM CORP·Filed 1995·Granted May 20, 1997·19 cites·4 claims
- 2564US2009227607A1Deazapurines useful as inhibitors of janus kinasesLEDEBOER MARK·Filed 2008·Application pending·0 cites
- 2664US2022323595A1Sustained delivery of angiopoetin-like 3 polypeptidesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2762US2020376129A1Sustained release delivery systems comprising traceless linkersNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2861US2014315931A1Deazapurines useful as inhibitors of janus kinasesVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2955US7902239B2Diaminotriazoles useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2007·Granted Mar 8, 2011·0 cites·6 claims
- 3055US5811455ACompounds useful for treating allergic or inflammatory diseasesSMITHKLINE BEECHAM CORP·Filed 1995·Granted Sep 22, 1998·10 cites·10 claims
- 3155US5095136AMethod for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediatesSQUIBB & SONS INC·Filed 1990·Granted Mar 10, 1992·5 cites·6 claims
- 3255US2012316186A1Deazapurines useful as inhibitors of janus kinasesLEDEBOER MARK·Filed 2012·Application pending·0 cites
- 3351US11389541B2Sustained delivery of angiopoetin-like 3 polypeptidesNOVARTIS AG·Filed 2019·Granted Jul 19, 2022·0 cites·18 claims
- 3444US6300372B13-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylatesSMITHKLINE BEECHAM CORP·Filed 1994·Granted Oct 9, 2001·5 cites·4 claims
- 3543US7645775B2Triazoles useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2005·Granted Jan 12, 2010·0 cites·12 claims
- 3641US5393788APhenylalkyl oxamidesSMITHKLINE BEECHAM CORP·Filed 1991·Granted Feb 28, 1995·4 cites·3 claims
- 3740US2003096813A1Compositions useful as inhibitors of GSK-3Filed 2002·Application pending·0 cites
- 3839US5144080AMethod for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediatesSQUIBB & SONS INC·Filed 1991·Granted Sep 1, 1992·1 cites·2 claims
- 3937US5710180APhenethylamine compoundsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Jan 20, 1998·1 cites·3 claims
- 4032US6172118B1CompoundsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Jan 9, 2001·0 cites·10 claims
- 4132US6118017ASubstituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-oneSMITHKLINE BEECHAM CORP·Filed 1999·Granted Sep 12, 2000·0 cites·10 claims
- 4231US5157146AMethod for preparing isoprenoid cyclopropane 1,1-dicarboxylatesSQUIBB & SONS INC·Filed 1991·Granted Oct 20, 1992·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Cornelia Forster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →